Innovative Solutions In Pre-Filled Syringes For Biologics And Ophthalmic Applications

The pre-filled syringes market has grown rapidly in recent years as a result of converging factors: the vast biologics market, a growing number of biosimilar entrants, the ongoing rise of self-administration, and rising chronic illness due to ageing populations.

There is not a solution that fits all the challenges. For this reason, Pharma Companies need tailored syringes fit for each intended uses.

In this webinar, Enrico Barichello, Product Manager for Syringe Platform in Stevanato Group and Alan Xu, Product Manager for Analytical Services in Stevanato Group, will be discussing the best strategy between customers and suppliers to select the right container based on the key features of the combination product.

Addressed Challenges

1. Streamline the integration of the primary drug containers and delivery systems
2. Tackling Biologics – complex, sensitive and hard-to-stabilize drugs
3. Acceleration of therapy moving from hospital to home care, driving adoption of drug delivery systems
4. Increased concentration of biologic formulations lead to higher viscosity solutions which are challenging to deliver accurately.

What You Will Learn

• Analytical services can simplify the journey of combination products from early-stage design, all the way through launch
• Specialized PFS syringes meet the key requirements of protein-based or high viscosity drugs
• Auto-injectors which help patient centricity and ease of use are dependent on specialized primary containers